Cogstate Limited (ASX:CGS)

Market Cap	435.93M
Revenue (ttm)	80.98M
Net Income (ttm)	15.47M
Shares Out	171.62M
EPS (ttm)	0.09
PE Ratio	28.56
Forward PE	27.70
Dividend	0.02 (0.79%)
Ex-Dividend Date	Aug 27, 2025

Volume	1,073,500
Average Volume	385,585
Open	2.550
Previous Close	2.520
Day's Range	2.530 - 2.610
52-Week Range	1.010 - 2.970
Beta	0.02
RSI	48.37
Earnings Date	Nov 20, 2025

About Cogstate

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophre...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.

Financial numbers in USD